Saltar al contenido
Merck

Saltar a

1A02420

USP

Aripiprazole Diquinolinone Butanediol

Pharmaceutical Analytical Impurity (PAI)

Sinónimos:

(7,7′-(butane-1,4-diylbis(oxy))bis(3,4-dihydroquinolin-2(1H)-one))

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas
Tamaño de envaseSKUDisponibilidadPrecio

Acerca de este artículo

Fórmula empírica (notación de Hill):
C22H24N2O4
Número CAS:
Peso molecular:
380.44
MDL number:
NACRES:
NA.24
UNSPSC Code:
41116107
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle


grade

pharmaceutical analytical impurity (PAI)

agency

USP

API family

aripiprazole

manufacturer/tradename

USP

application(s)

pharmaceutical

format

neat

storage temp.

2-8°C

General description

Aripiprazole Diquinolinone Butanediol is a USP Pharmaceutical Analytical Impurity (PAI).

USP PAI are a product line of impurities suitable for research and analytical purposes, which help to ensure the quality and safety of medicines.

Associated Drug Substance: Aripiprazole.

For more information about this PAI, visit here.

Application

Aripiprazole Diquinolinone Butanediol (USP PAI) is intended for use in analytical testing to detect, identify, and measure pharmaceutical impurities.

Features and Benefits

USP PAI advance your early analytical R&D and process development. PAI can be used in the following applications:
1. Conduct analytical tests during early formulation feasibility studies.
2. Determine degradation impurities produced during stress studies.
3. Develop, validate, and transfer analytical methods.
4. Perform spiking studies during process R&D to demonstrate depletion upon recrystallization.
5. Record retention times and/or spectra
6. Determine relative response factors.
7. Identify unknown impurities that formed during ICH stability conditions.
8. Identify impurities that are present in the Reference Listed Drug
9. Test for and profile impurities not listed in drug substance and drug product monographs.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 1

Este artículo
1A024801A025501A02440
grade

pharmaceutical analytical impurity (PAI)

grade

pharmaceutical analytical impurity (PAI)

grade

pharmaceutical analytical impurity (PAI)

grade

pharmaceutical analytical impurity (PAI)

manufacturer/tradename

USP

manufacturer/tradename

USP

manufacturer/tradename

USP

manufacturer/tradename

USP

application(s)

pharmaceutical

application(s)

pharmaceutical

application(s)

pharmaceutical

application(s)

pharmaceutical

format

neat

format

neat

format

neat

format

neat

API family

aripiprazole

API family

aripiprazole

API family

aripiprazole

API family

aripiprazole

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C


Clase de almacenamiento

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos


Protocolos

Aripiprazole, an atypical antipsychotic, treats schizophrenia, bipolar disorder, and major depressive disorder.





Número de artículo de comercio global

SKUGTIN
1A02420-25MG04065269107439

Questions

Reviews

No rating value

Active Filters